The value of application and prospect of core outcome set in evidence-based traditional Chinese medicine research

QIU Rui-jin; WAN Si-qi; GUAN Zhi-yue; ZHANG Xin-yi; SHANG Hong-cai

doi:10.16025/j.1674-1307.2023.05.003

您当前的位置：

首页 >

文章列表页 >

The value of application and prospect of core outcome set in evidence-based traditional Chinese medicine research

更新时间：2023-06-25

- The value of application and prospect of core outcome set in evidence-based traditional Chinese medicine research
- Beijing Journal of Traditional Chinese Medicine Vol. 42, Issue 5, Pages: 470-474(2023)
- 作者机构：
  
  1.北京中医药大学东直门医院中医内科学教育部和北京市重点实验室，北京 100700
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2023.05.003
  CLC：
扫描看全文
邱瑞瑾，万思琦，关之玥，等.核心指标集在循证中医药学研究中的应用价值及前景分析［J］.北京中医药，2023，42（5）：470-474.

QIU Rui-jin,WAN Si-qi,GUAN Zhi-yue,et al.The value of application and prospect of core outcome set in evidence-based traditional Chinese medicine research[J]. Beijing Journal of Traditional Chinese Medicine,2023,42(05):470-474.
邱瑞瑾，万思琦，关之玥，等.核心指标集在循证中医药学研究中的应用价值及前景分析［J］.北京中医药，2023，42（5）：470-474. DOI： 10.16025/j.1674-1307.2023.05.003.

QIU Rui-jin,WAN Si-qi,GUAN Zhi-yue,et al.The value of application and prospect of core outcome set in evidence-based traditional Chinese medicine research[J]. Beijing Journal of Traditional Chinese Medicine,2023,42(05):470-474. DOI： 10.16025/j.1674-1307.2023.05.003.

摘要

自核心指标集的概念被引入中医药领域以来，经过近10年的发展，已有近100项中医药领域核心指标集在有效性试验结局指标测量（COMET）行动的数据库及中医药循证研究注册平台进行注册。截至2022年9月，已有10项中医药领域核心指标集研究公布结果，对其应用场景及引用情况进行分析发现，核心指标集在中医药领域的应用价值并未完全被开发。笔者认为，核心指标集在循证中医药学的原始研究、二次研究及转化研究等多个领域均具有极大的应用价值，核心指标集的应用不仅可以提高相关研究中结局指标报告的一致性，提高研究价值，减少浪费，也能促进相关成果的推广及应用。

Abstract

The concept of core outcome set（COS）was introduced into the field of traditional Chinese medicine（TCM）since 10 years ago.Now nearly 100 COS in the field of TCM have been registered in the database of the Core Outcome Measures in Effectiveness Trials（COMET）and the Registry Platform for Evidence Based TCM.By September 2022，10 COS in the field of TCM had been reported.After analyzing the settings and citation of these COS，the authors found that the citation of the COS in clinical trials and system reviews should be improved，and the value of application for the COS in TCM has not been fully considered.The authors believe that COS has great application value in multiple fields such as original research，secondary research，and transformation research in evidence-based TCM.COS can not only improve the consistency of outcomes reporting in research，improve research value and reduce waste，but also promote the promotion and application of research results.

关键词

核心指标集循证中医药应用方法学

Keywords

core outcome setsevidence-based traditional Chinese medicineapplicationmethodology

references

邱瑞瑾.中医临床研究核心指标集的方法构建[D].北京：北京中医药大学，2018.

李心怡,石兆峰,胡嘉元,等.针刺治疗偏头痛核心结局指标集的建立[J].世界科学技术-中医药现代化，2020，22(1):7-12.

QIU R,ZHAO C,LIANG T,et al.Core outcome set for clinical trials of COVID-19 based on traditional Chinese and western medicine[J].J Front Pharmacol，2020，11:781.

万颖.慢性腰痛中医临床研究核心结局指标集的构建 [D].北京：北京中医药大学，2021.

张明妍,张俊华,蔡慧姿,等.稳定型心绞痛中医药临床试验核心指标集研制[J].针灸和草药（英文），2021，1(1):39-48.

谢倩文,肖晶旻,邓雪仪,等.建立中医药治疗缺血性卒中核心结局指标集的初步研究[J].中医杂志，2022，63(3):220-228.

LI G,HAN R,LIN M,et al.Developing a core outcome set for clinical trials of Chinese medicine for hyperlipidemia[J].Front Pharmacol，2022，13:847101.

孙亚男,何丽云,雒琳,等.中医药治疗慢性乙型肝炎临床试验的核心结局指标集研究[J].中华中医药杂志，2020，35(9):4684-4688.

杨继,张垚,张运娇,等.基于主成分分析的中医药治疗慢性心力衰竭临床随机对照试验核心结局指标研究[J].中西医结合心脑血管病杂志，2021，19(15):2496-2509,2515.

邱瑞瑾,孙杨,韩松洁,等.非瓣膜性房颤中医核心证候指标集的构建[J].中国循证医学杂志，2021，21(12):1480-1488.

WILLIAMSON PR,BARRINGTON H,BLAZEBY JM,et al.Review finds core outcome set uptake in new studies and systematic reviews needs improvement[J].J Clin Epidemiol，2022，150:154-164.

GUYATT GH,OXMAN AD,KUNZ R,et al.GRADE guidelines:2.Framing the question and deciding on important outcomes[J].J Clin Epidemiol，2011，64:395-400.

邱瑞瑾,孙杨,钟长鸣,等.中医核心证候指标集的构建思路[J].中国循证医学杂志,2021,21(11):1353-1357.

CHEN KJ,LU AP.Situation of integrative medicine in china: results from a national survey in 2004[J].Chin J Integr Med，2006，12:161-165.

董欣,石悦.中成药药品说明书的现状调查分析[J].中国中医药信息杂志,2015,22(3):117-120.

QIU R,HAN S,WEI X,et al.Development of a core outcome set for the benefits and adverse events of acute heart failure in clinical trials of traditional Chinese medicine and western medicine: A Study Protocol[J].Front Med(Lausanne),2021,8:677068.

KLOKKER L,TUGWELL P,FURST DE,et al.Developing an OMERACT core outcome set for assessing safety components in rheumatology trials:The OMERACT safety working group[J].J Rheumatol,2017,44(12):1916-1919.

邱瑞瑾,钟长鸣,关曼柯,等.中西药联用临床安全性评价应引入核心指标集[J].中国循证医学杂志,2020,20(5):511-514.

QIU R,ZHONG C,WAN S,et al.Developing a core outcome set for assessing clinical safety outcomes of cardiovascular diseases in clinical trials of integrated traditional Chinese medicine and Western medicine: study protocol[J].Trials,2022,23(1):239.

李慧,陈耀龙,韦当,等.中医(中西医结合)临床实践指南制修订方法:临床问题的构建[J].中华中医药杂志,2016,31(6):2202-2205.

杨克虎,译.世界卫生组织指南制定手册[M].兰州：兰州大学出版社，2013.

O'ROURKE B,OORTWIJN W,SCHULLER T,et al.The new definition of health technology assessment:A milestone in international collaboration[J].Int J Technol Assess Health Care,2020,36(3):187-190.

World Health Organization.Institutionalizing health technology assessment mechanisms: a how to guide[EB/OL][2022-09-30].https://www.who.int/publications-detail-redirect/9789240020665https://www.who.int/publications-detail-redirect/9789240020665.

GOETGHEBEUR MM,WAGNER M,KHOURY H,et al.Evidence and value：impact on DEcisionMaking:the EVIDEM framework and potential applications[J].BMC Health Serv Res，2008,8:270.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰